BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 7935355)

  • 41. Studies on the soluble phosphodiesterases of chicken gizzard smooth muscle.
    Birnbaum RJ; Head JF
    Biochem J; 1983 Dec; 215(3):627-36. PubMed ID: 6318728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The identification and characterization of two cyclic nucleotide phosphodiesterases from bovine adrenal medulla.
    Sabatine JM; Coffee CJ
    Arch Biochem Biophys; 1986 Aug; 249(1):95-105. PubMed ID: 3017224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective alteration of Ca2+-dependent and Ca2+-independent cyclic nucleotide phosphodiesterase activity in rat cerebral cortex by cyclic nucleotides and their analogs.
    Davis CW
    Biochim Biophys Acta; 1982 Jul; 705(1):1-7. PubMed ID: 6288105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
    Hidaka H; Endo T
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of trifluoperazine on cyclic nucleotide phosphodiesterase activity in crude homogenates of bovine adrenal medulla.
    Crimaldi AA; Kuo IC; Coffee CJ
    Ann N Y Acad Sci; 1980; 356():367-8. PubMed ID: 6263155
    [No Abstract]   [Full Text] [Related]  

  • 46. Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.
    Yu H; Cai JJ; Lee HC
    Mol Pharmacol; 1996 Sep; 50(3):549-55. PubMed ID: 8794893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
    Sobolev AS; Rybalkin SD
    Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
    Bellamy TC; Garthwaite J
    Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
    Lugnier C; Gauthier C; Le Bec A; Soustre H
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Filipin prevents and reverses insulin stimulation of rat adipocyte phosphodiesterase.
    Ling WI; Cheung WY
    Mol Cell Endocrinol; 1979 May; 14(2):113-22. PubMed ID: 223898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the rabbit myometrium].
    Osipenko AA; Prishchepa LA; Kurskiĭ MD
    Ukr Biokhim Zh (1978); 1986; 58(4):26-31. PubMed ID: 3016961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple forms of cyclic nucleotide phosphodiesterases in normal and goitrous rat thyroid.
    Sharma RV; Bhalla RC
    Arch Biochem Biophys; 1980 Jun; 202(1):210-20. PubMed ID: 6249217
    [No Abstract]   [Full Text] [Related]  

  • 54. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The calcium/calmodulin-dependent phosphodiesterase PDE1C down-regulates glucose-induced insulin secretion.
    Han P; Werber J; Surana M; Fleischer N; Michaeli T
    J Biol Chem; 1999 Aug; 274(32):22337-44. PubMed ID: 10428803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN; Bobruskin ID; Severin SE
    Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and characterization of cyclic nucleotide phosphodiesterases.
    Purcell EB; Tamayo R
    Methods Mol Biol; 2013; 1016():235-43. PubMed ID: 23681583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium-independent activation of calcium ion dependent cyclic nucleotide phosphodiesterase by synthetic compounds: quinazolinesulfonamide derivatives.
    Tanaka T; Yamada E; Sone T; Hidaka H
    Biochemistry; 1983 Mar; 22(5):1030-4. PubMed ID: 6301535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of soluble uterine cyclic nucleotide phosphodiesterase.
    Gardner EA; Thompson WJ; Strada SJ; Stancel GM
    Biochemistry; 1978 Jul; 17(15):2995-3000. PubMed ID: 212098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates.
    Kincaid RL; Manganiello VC
    Methods Enzymol; 1988; 159():457-70. PubMed ID: 2842611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.